US Patent Issued to Athergen on Sept. 9 for "Composition comprising nicotinamide mononucleotide and leucomethylene blue" (New Hampshire Inventor)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,394, issued on Sept. 9, was assigned to Athergen Inc. (Dover, Del.).

"Composition comprising nicotinamide mononucleotide and leucomethylene blue" was invented by Joseph Chalifoux (Nashua, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A cell reprogramming composition and method wherein the composition includes a base molecule, Beta-nicotinamide mononucleotide, trichostatin A and zwitterionic liposomes and wherein the method includes receiving a cell and reprogramming agents, wherein the reprogramming agents comprise Oct-4, Sox 2 and Klf4, to reprogram the cell to an embryonic state."

The patent was filed on Jan. 6, 2023, under Application No....